Loading organizations...
Key people at Madryn Asset Management.
Madryn Asset Management is an alternative asset management firm, strategically investing in innovative healthcare companies. The firm focuses on funding enterprises developing unique products, technologies, and services within the sector. Its core capability lies in a specialized understanding of the healthcare landscape, enabling precise capital deployment for significant advancement.
Founded in 2017 by Dr. Avinash Amin, Co-Founder and Managing Partner, the firm leverages his unique background. Dr. Amin’s insight stemmed from his physician experience, recognizing the need for informed capital to accelerate medical innovation. His medical pedigree provides Madryn a distinct lens for evaluating complex healthcare opportunities.
Madryn Asset Management primarily serves emerging and established healthcare companies seeking growth capital for their solutions. The firm’s long-term vision is to foster global healthcare advancements by strategically partnering with pioneering entities. Through targeted investments, Madryn aims to facilitate development and commercialization of next-generation medical solutions, shaping future health.
Key people at Madryn Asset Management.
Madryn Asset Management has 3 tracked investments across 2 companies. The latest tracked deal is $28.0M Series E in Monteris Medical in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 12, 2026 | Monteris Medical | $28.0M Series E | — | Birchview Capital, CU Healthcare Innovation Fund, Innovahealth Partners, Mayank Taneja, Robert Lake |
| Oct 28, 2022 | Monteris Medical | $73.0M Debt / Series D Extension | Mortimer Berkowitz, Madryn Asset Management | Birchview Capital |
| Dec 24, 2020 | SomaLogic | $81.0M Series A Extension | ELI Casdin | Amgen Ventures, Boston Millennia Partners, Farallon Capital Management, Fiscus Ventures, Foresite Capital, Intermountain Ventures, Janus Henderson Investors, Logos Capital, Monashee Investment Management, Mossrock Capital, NEC Solution Innovators, Novartis, Redmile Group, Reimagined Ventures, Revelation Partners, Soleus Capital, ROY Smythe, T. Rowe Price Associates, Ziff Capital Partners |